PASITHEA THERAPEUTICS CORP. (KTTA) Return on equity 2021–2022
PASITHEA THERAPEUTICS CORP. (KTTA) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-32.8%FY2022 · since FY2021: -4.2% → -32.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -32.8% | -28.6 pp |
| FY2021 | -4.2% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice